Anzeige
Mehr »
Donnerstag, 31.07.2025 - Börsentäglich über 12.000 News
Der KI-Energiekollaps: Uran auf kritischem Kurs - und Foremost Clean Energy entflammt den Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 931150 | ISIN: NO0010000045 | Ticker-Symbol: PHS
Frankfurt
31.07.25 | 08:05
5,700 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PHOTOCURE ASA Chart 1 Jahr
5-Tage-Chart
PHOTOCURE ASA 5-Tage-Chart
RealtimeGeldBriefZeit
5,4505,67018:49

Aktuelle News zur PHOTOCURE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiPhotocure ASA reports Q2 results2
MiPHOTOCURE ASA Q2 Profit Retreats1
MiPhotocure Q2 2025 presentation: Record revenue growth amid strategic expansion7
MiPhotocure ASA: Results for the second quarter of 2025237OSLO, Norway, July 30, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 135.6 million in the second quarter of 2025 (Q2 2024: NOK 122.4 million)...
► Artikel lesen
MiPhotocure Q2 2025: Rekordumsatz und strategische Expansion/n5
22.07.Photocure ASA: Invitation to presentation of second quarter and first half year 2025 financial results1
23.06.Photocure ASA - Share option grant1
08.05.Photocure ASA reports Q1 results1
PHOTOCURE Aktie jetzt für 0€ handeln
08.05.Photocure Q1 2025 presentation: 7% revenue growth amid strategic expansion initiatives5
08.05.Photocure ASA: Results for the first quarter of 2025895OSLO, Norway, May 8, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 125.3 million in the first quarter of 2025 (Q1 2024: NOK 116.8 million)...
► Artikel lesen
05.05.Photocure ASA: Annual general meeting held1
30.04.Photocure ASA: Invitation to presentation of first quarter 2025 financial results2
29.04.Photocure ASA: Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making2
11.04.Photocure ASA - Notice of the Annual General Meeting 5 May 20251
11.04.Photocure ASA: Annual Report 20241
31.03.Photocure ASA: Transactions made under share buyback program2
26.03.Photocure ASA - Share option grant to Vice President and General Manager EMEA-
26.03.Photocure ASA: Photocure appoints Jane Healy as Vice President and General Manager EMEA3
26.03.Photocure appoints Jane Healy as Vice President and General Manager EMEA660OSLO, Norway, March 26, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced the appointment of Jane Healy as Vice President and General Manager EMEA. Ms....
► Artikel lesen
24.03.Photocure: Clinical data presentations at the European Association of Urology (EAU) 2025 congress highlight the benefits of using Blue Light Cystoscopy in bladder cancer328OSLO, Norway, March 24, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two abstract presentations at the 2025 European Association of Urology congress...
► Artikel lesen
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1